
Adolf D. Berhane
Examiner (ID: 2145, Phone: (571)272-2077 , Office: P/2838 )
| Most Active Art Unit | 2838 |
| Art Unit(s) | 2102, 2111, 2722, 2838, 2899 |
| Total Applications | 4100 |
| Issued Applications | 3647 |
| Pending Applications | 180 |
| Abandoned Applications | 306 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5120765
[patent_doc_number] => 20070142480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Alleviation of pain in osteoarthritis by means of intra-articular implantation of perfluorodecalin.'
[patent_app_type] => utility
[patent_app_number] => 11/306155
[patent_app_country] => US
[patent_app_date] => 2005-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6199
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20070142480.pdf
[firstpage_image] =>[orig_patent_app_number] => 11306155
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/306155 | Alleviation of pain in osteoarthritis by means of intra-articular implantation of perfluorodecalin. | Dec 17, 2005 | Abandoned |
Array
(
[id] => 7693863
[patent_doc_number] => 20070015823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Ambruticin VS compounds'
[patent_app_type] => utility
[patent_app_number] => 11/305802
[patent_app_country] => US
[patent_app_date] => 2005-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21718
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20070015823.pdf
[firstpage_image] =>[orig_patent_app_number] => 11305802
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/305802 | Ambruticin VS compounds | Dec 15, 2005 | Abandoned |
Array
(
[id] => 5120680
[patent_doc_number] => 20070142395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Treatment of sexual dysfunction with 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2(1H)-quinolone or salt thereof'
[patent_app_type] => utility
[patent_app_number] => 11/305277
[patent_app_country] => US
[patent_app_date] => 2005-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6928
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20070142395.pdf
[firstpage_image] =>[orig_patent_app_number] => 11305277
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/305277 | Treatment of sexual dysfunction with 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2(1H)-quinolone or salt thereof | Dec 15, 2005 | Abandoned |
Array
(
[id] => 5649839
[patent_doc_number] => 20060135574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Novel uses for estrogen beta agonists'
[patent_app_type] => utility
[patent_app_number] => 11/304037
[patent_app_country] => US
[patent_app_date] => 2005-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12729
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135574.pdf
[firstpage_image] =>[orig_patent_app_number] => 11304037
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/304037 | Novel uses for estrogen beta agonists | Dec 14, 2005 | Abandoned |
Array
(
[id] => 5913682
[patent_doc_number] => 20060128744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Use of 5-HT6 agonist for the treatment and prevention of neurodegenerative disorders'
[patent_app_type] => utility
[patent_app_number] => 11/301445
[patent_app_country] => US
[patent_app_date] => 2005-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5657
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20060128744.pdf
[firstpage_image] =>[orig_patent_app_number] => 11301445
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/301445 | Use of 5-HT6 agonist for the treatment and prevention of neurodegenerative disorders | Dec 12, 2005 | Abandoned |
Array
(
[id] => 5648277
[patent_doc_number] => 20060134009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Low dose corticosteroid powders for inhalation'
[patent_app_type] => utility
[patent_app_number] => 11/302535
[patent_app_country] => US
[patent_app_date] => 2005-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5214
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134009.pdf
[firstpage_image] =>[orig_patent_app_number] => 11302535
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/302535 | Low dose corticosteroid powders for inhalation | Dec 12, 2005 | Abandoned |
Array
(
[id] => 5596859
[patent_doc_number] => 20060160777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'New use of GABAbeta receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 11/302721
[patent_app_country] => US
[patent_app_date] => 2005-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4485
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160777.pdf
[firstpage_image] =>[orig_patent_app_number] => 11302721
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/302721 | New use of GABAbeta receptor agonists | Dec 12, 2005 | Abandoned |
Array
(
[id] => 5694748
[patent_doc_number] => 20060154895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Method of treating acquired immunedeficiency syndrome'
[patent_app_type] => utility
[patent_app_number] => 11/298551
[patent_app_country] => US
[patent_app_date] => 2005-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1785
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20060154895.pdf
[firstpage_image] =>[orig_patent_app_number] => 11298551
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/298551 | Method of treating acquired immunedeficiency syndrome | Dec 7, 2005 | Abandoned |
Array
(
[id] => 6295739
[patent_doc_number] => 20100160310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => '2,4 (4,6) PYRIMIDINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 11/720681
[patent_app_country] => US
[patent_app_date] => 2005-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50497
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20100160310.pdf
[firstpage_image] =>[orig_patent_app_number] => 11720681
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/720681 | 2,4 (4,6) pyrimidine derivatives | Dec 7, 2005 | Issued |
Array
(
[id] => 5667730
[patent_doc_number] => 20060173080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'Methods of modulating TNF using bupropion'
[patent_app_type] => utility
[patent_app_number] => 11/291730
[patent_app_country] => US
[patent_app_date] => 2005-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12305
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20060173080.pdf
[firstpage_image] =>[orig_patent_app_number] => 11291730
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/291730 | Methods of modulating TNF using bupropion | Nov 30, 2005 | Abandoned |
Array
(
[id] => 5614432
[patent_doc_number] => 20060116360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Method of administering anti-angiogenic agents and a method of treating disease using same'
[patent_app_type] => utility
[patent_app_number] => 11/288989
[patent_app_country] => US
[patent_app_date] => 2005-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11998
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20060116360.pdf
[firstpage_image] =>[orig_patent_app_number] => 11288989
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/288989 | Method of administering anti-angiogenic agents and a method of treating disease using same | Nov 28, 2005 | Abandoned |
Array
(
[id] => 5620160
[patent_doc_number] => 20060189694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Composition and method for treating neurological disease'
[patent_app_type] => utility
[patent_app_number] => 11/286448
[patent_app_country] => US
[patent_app_date] => 2005-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11249
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20060189694.pdf
[firstpage_image] =>[orig_patent_app_number] => 11286448
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/286448 | Composition and method for treating neurological disease | Nov 22, 2005 | Issued |
Array
(
[id] => 5716125
[patent_doc_number] => 20060079488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Methods of treating and preventing bone loss'
[patent_app_type] => utility
[patent_app_number] => 11/286237
[patent_app_country] => US
[patent_app_date] => 2005-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13953
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20060079488.pdf
[firstpage_image] =>[orig_patent_app_number] => 11286237
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/286237 | Methods of treating and preventing bone loss | Nov 22, 2005 | Abandoned |
Array
(
[id] => 5844447
[patent_doc_number] => 20060122179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Methods and compositions using JNK inhibitors for treatment and management of central nervous system injury'
[patent_app_type] => utility
[patent_app_number] => 11/286128
[patent_app_country] => US
[patent_app_date] => 2005-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20762
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20060122179.pdf
[firstpage_image] =>[orig_patent_app_number] => 11286128
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/286128 | Methods and compositions using JNK inhibitors for treatment and management of central nervous system injury | Nov 21, 2005 | Abandoned |
Array
(
[id] => 4484690
[patent_doc_number] => 07902198
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-08
[patent_title] => 'Crystalline aripiprazole solvates'
[patent_app_type] => utility
[patent_app_number] => 11/281498
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 5394
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/902/07902198.pdf
[firstpage_image] =>[orig_patent_app_number] => 11281498
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/281498 | Crystalline aripiprazole solvates | Nov 17, 2005 | Issued |
Array
(
[id] => 8082217
[patent_doc_number] => 08148426
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-03
[patent_title] => 'Bis(thio-hydrazide amides) for increasing Hsp70 expression'
[patent_app_type] => utility
[patent_app_number] => 11/281923
[patent_app_country] => US
[patent_app_date] => 2005-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15503
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/148/08148426.pdf
[firstpage_image] =>[orig_patent_app_number] => 11281923
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/281923 | Bis(thio-hydrazide amides) for increasing Hsp70 expression | Nov 16, 2005 | Issued |
Array
(
[id] => 5694733
[patent_doc_number] => 20060154880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases'
[patent_app_type] => utility
[patent_app_number] => 11/271963
[patent_app_country] => US
[patent_app_date] => 2005-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15989
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20060154880.pdf
[firstpage_image] =>[orig_patent_app_number] => 11271963
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/271963 | Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases | Nov 13, 2005 | Abandoned |
Array
(
[id] => 8784773
[patent_doc_number] => 08431616
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-30
[patent_title] => 'Method for producing a disinfecting agent'
[patent_app_type] => utility
[patent_app_number] => 12/084594
[patent_app_country] => US
[patent_app_date] => 2005-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1653
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12084594
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/084594 | Method for producing a disinfecting agent | Nov 13, 2005 | Issued |
Array
(
[id] => 5844751
[patent_doc_number] => 20060122279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Hydrophobic polyamine amides as potent lipopolysaccharide sequestrants'
[patent_app_type] => utility
[patent_app_number] => 11/271743
[patent_app_country] => US
[patent_app_date] => 2005-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15158
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20060122279.pdf
[firstpage_image] =>[orig_patent_app_number] => 11271743
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/271743 | Hydrophobic polyamine amides as potent lipopolysaccharide sequestrants | Nov 13, 2005 | Abandoned |
Array
(
[id] => 5748402
[patent_doc_number] => 20060111334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Oral solid dosage forms containing a low dose of estradiol'
[patent_app_type] => utility
[patent_app_number] => 11/262952
[patent_app_country] => US
[patent_app_date] => 2005-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9396
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20060111334.pdf
[firstpage_image] =>[orig_patent_app_number] => 11262952
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/262952 | Oral solid dosage forms containing a low dose of estradiol | Oct 31, 2005 | Issued |